Companies / AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc.

Nasdaq: ANTXCIK 1880438MENLO PARK, CA

Financials

Revenue—
Net income$-35.17M
Total debt—
Cash$44.32M
Diluted EPS$-1.16
Shares outstanding37.7M

Ownership

37.7M shares outstanding · as of Aug 6, 2026
2.9%Insiders
Ownership
Insiders2.87%1,083,942
10%+ / strategic7.88%2,975,164
Institutions32.16%12,135,125
Public float57.09%21,542,006

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
Eric EasomCEOChief Executive Officer · Director
0.98%368,630
Eizen Joshua MSee Remarks
0.55%207,499
Chanda SanjayChief Development Officer
0.31%118,823
Day LucyChief Financial Officer
0.31%118,363
Marks Gilbert LynnDirector
0.20%75,309
Williams Sarah JoannePrincipal Accounting Officer
0.18%66,848
Prior Stephen DavidChief Strategy Officer
0.16%59,086
Aziz KabeerDirector
0.14%52,479
Martin Patricia A.Director
0.04%16,905
FitzPatrick Margaret MDirector
——

Institutional holders 45

View all →
HolderValue% of shares
BlackRock, Inc.$8.06M4.41%
Millennium Management LLC$7.60M5.89%
Adage Capital Partners Gp, L.L.C.$3.42M2.65%
Almitas Capital LLC$1.69M3.92%
State Street Corporation$1.51M0.83%
Vanguard Group Inc$1.23M2.86%
Geode Capital Management, LLC$980.8K0.76%
Pfizer Inc$815.4K1.90%
Stonepine Capital Management, LLC$715.5K1.66%
Cantor Fitzgerald, L. P.$684.0K0.53%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 5, 2026Eizen Joshua M
Executive
SellCommon Stock$17.9K-18K
-10.11%
159,430
0.42% of shares
low
Jan 6, 2026Eizen Joshua M
Executive
SellCommon Stock$7.0K-7K
-4.35%
152,499
0.40% of shares
low
Jan 6, 2026Chanda Sanjay
Executive
SellCommon Stock$6.0K-6K
-7.28%
75,823
0.20% of shares
low
Jan 6, 2026Day Lucy
Executive
SellCommon Stock$5.6K-6K
-6.82%
75,363
0.20% of shares
low
Jan 5, 2026Prior Stephen David
Executive
SellCommon Stock$3.6K-4K
-5.50%
61,944
0.16% of shares
low
Jan 5, 2026Day Lucy
Executive
SellCommon Stock$3.3K-3K
-3.91%
80,875
0.21% of shares
low
Jan 5, 2026Chanda Sanjay
Executive
SellCommon Stock$3.3K-3K
-3.87%
81,779
0.22% of shares
low
Jan 6, 2026Prior Stephen David
Executive
SellCommon Stock$2.9K-3K
-4.61%
59,086
0.16% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Integrated Core Strategies (US) LLCPassive13G———
Almitas Capital LLCPassive13G—2,975,164—
Commodore Capital LPPassive13G———
Eric EasomPassive13G/A———
Vivo Opportunity Fund Holdings, L.P.Passive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ANTX——037326105—